Kebir et al. [27] reported that endothelial cells of BBB express IL-17 and IL-22 receptors in autoimmune inflammatory diseases such as multiple sclerosis and that binding to the receptors by IL-17 and IL-22 disrupts BBB tight junctions and facilitates Th17 infiltration into the brain. Here, IL22 is linked to multiple sclerosis.